Mount Sinai Launches AI-Powered Ophthalmic Center
The center will research the use of new technologies to improve the diagnosis process.
Mount Sinai’s Icahn School of Medicine launched a new initiative focused on using new technology to improve the diagnosis process.
The Center for OphthalmicArtificial Intelligence and Human Health in New York will also provide risk assessment for systemic health conditions. The center will use AI technology across three areas: the tele-retina program, the tele-consult program, and eye stroke service.
In a press release, James C. Tsai, MD, Delafield-Rogers professor and chair of ophthalmology at Icahn Mount Sinai and the Mount Sinai Health System, said, “Our department is excited to be at the forefront of ophthalmic innovation in AI and Human Health and play a critical role in validating and implementing the most promising technologies. We anticipate that the Center will help revolutionize and transform population-based health, thereby enhancing quality and equitable care. Besides the more timely diagnosis and referral of community-based ocular conditions, we will better predict cardiovascular health in the future since recent research has shown that cardiovascular risk factors can be determined from AI-guided analysis of retinal fundus photographs. No other specialty in medicine allows such an unimpeded view and assessment of the cardiovascular and neurological systems.”
Louis Pasquale, MD, chair of ophthalmology at Mount Sinai Hospital, and Alon Harris, PhD, vice chair of international research and academic affairs at Icahn Mount Sinai, will serve as co-directors of the center.
